SOTAGLIFLOZIN for Chronic left ventricular failure: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 31 adverse event reports in the FDA FAERS database where SOTAGLIFLOZIN was used for Chronic left ventricular failure.
Most Reported Side Effects for SOTAGLIFLOZIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dizziness | 51 | 10.8% | 0 | 3 |
| Diarrhoea | 45 | 9.5% | 0 | 1 |
| Therapy interrupted | 28 | 5.9% | 0 | 6 |
| Death | 24 | 5.1% | 24 | 0 |
| Off label use | 24 | 5.1% | 0 | 1 |
| Dyspnoea | 22 | 4.7% | 0 | 2 |
| Headache | 21 | 4.5% | 0 | 0 |
| Urinary tract infection | 21 | 4.5% | 0 | 6 |
| Product use issue | 20 | 4.2% | 0 | 5 |
| Nausea | 18 | 3.8% | 0 | 0 |
| Fungal infection | 16 | 3.4% | 0 | 2 |
| Fatigue | 14 | 3.0% | 0 | 1 |
| Vomiting | 14 | 3.0% | 0 | 0 |
| Drug ineffective | 13 | 2.8% | 0 | 1 |
| Hospitalisation | 12 | 2.5% | 0 | 12 |
Other Indications for SOTAGLIFLOZIN
Product used for unknown indication (292)
Cardiac failure (31)
Cardiac failure congestive (29)
Type 2 diabetes mellitus (17)
Cardiac disorder (11)
Left ventricular failure (8)
Cardiomyopathy (5)
Other Drugs Used for Chronic left ventricular failure
SACUBITRIL\VALSARTAN (276)
TAFAMIDIS (31)
SPIRONOLACTONE (15)
TORSEMIDE (9)
IVABRADINE (7)
BISOPROLOL (6)
BUMETANIDE (6)
FUROSEMIDE (6)
CANDESARTAN CILEXETIL (5)
CARVEDILOL (5)